Back to NVCR
Hennion & Walsh Asset Management, Inc. → NVCR
Hennion & Walsh Asset Management, Inc. NVCR Position History
NovoCure Limited • Healthcare
Quarters held
5
Latest value
$880K
Q3 2026
Peak value
$880K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $534K |
| Q4 2025 | $701K |
| Q1 2026 | $598K |
| Q2 2026 | $824K |
| Q3 2026 | $880K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $880K | 55.2K | — | — |
| Q2 2026 | $824K | 54.4K | — | — |
| Q1 2026 | $598K | 54.9K | — | — |
| Q4 2025 | $701K | 54.2K | — | — |
| Q3 2025 | $534K | 41.3K | — | — |
Other funds holding NVCR
$196M
$187M
$130.6M
$124.5M
$88.9M
$78.7M
$66M